Outcomes of Catheter Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy Without Background Implantable Cardioverter Defibrillator Therapy

Marcus, 1982, Right ventricular dysplasia: a report of 24 adult cases, Circulation, 65, 384, 10.1161/01.CIR.65.2.384 Marcus, 2010, Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria, Circulation, 121, 1533, 10.1161/CIRCULATIONAHA.108.840827 Basso, 1996, Arrhythmogenic right ventricular cardiomyopathy: dysplasia, dystrophy, or myocarditis?, Circulation, 94, 983, 10.1161/01.CIR.94.5.983 Santangeli, 2012, Fragmented and delayed electrograms within fibrofatty scar predict arrhythmic events in arrhythmogenic right ventricular cardiomyopathy: results from a prospective risk stratification study, Heart Rhythm, 9, 1200, 10.1016/j.hrthm.2012.03.057 Marcus, 2009, Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry, J Am Coll Cardiol, 54, 609, 10.1016/j.jacc.2009.04.052 Garcia, 2009, Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/dysplasia, Circulation, 120, 366, 10.1161/CIRCULATIONAHA.108.834903 Bai, 2011, Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation, Circ Arrhythm Electrophysiol, 4, 478, 10.1161/CIRCEP.111.963066 Philips, 2012, Outcomes of catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy, Circ Arrhythm Electrophysiol, 5, 499, 10.1161/CIRCEP.111.968677 Berruezo, 2012, Combined endocardial and epicardial catheter ablation in arrhythmogenic right ventricular dysplasia incorporating scar dechanneling technique, Circ Arrhythm Electrophysiol, 5, 111, 10.1161/CIRCEP.110.960740 Santangeli, 2015, Long-Term outcome with catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy, Circ Arrhythm Electrophysiol, 8, 1413, 10.1161/CIRCEP.115.003562 Orgeron, 2017, Implantable cardioverter-defibrillator therapy in arrhythmogenic right ventricular dysplasia/cardiomyopathy: predictors of appropriate therapy, outcomes, and complications, J Am Heart Assoc, 6, e006242, 10.1161/JAHA.117.006242 Corrado, 2003, Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia, Circulation, 108, 3084, 10.1161/01.CIR.0000103130.33451.D2 Caverly, 2012, Patient preference in the decision to place implantable cardioverter-defibrillators, Arch Intern Med, 172, 1104, 10.1001/archinternmed.2012.2177 Selvaraj, 2017, Reuse of pacemakers, defibrillators and cardiac resynchronisation devices, Heart Asia, 9, 30, 10.1136/heartasia-2016-010828 Chia, 2017, Disparity between indications for and utilization of implantable cardioverter defibrillators in Asian patients with heart failure, Circ Cardiovasc Qual Outcomes, 10, e003651, 10.1161/CIRCOUTCOMES.116.003651 McKenna, 1994, Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy, Br Heart J, 71, 215, 10.1136/hrt.71.3.215 Li, 2012, Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy, J Cardiovasc Electrophysiol, 23, 750, 10.1111/j.1540-8167.2011.02288.x Polin, 2011, Endocardial unipolar voltage mapping to identify epicardial substrate in arrhythmogenic right ventricular cardiomyopathy/dysplasia, Heart Rhythm, 8, 76, 10.1016/j.hrthm.2010.09.088 Sosa, 1996, A new technique to perform epicardial mapping in the electrophysiology laboratory, J Cardiovasc Electrophysiol, 7, 531, 10.1111/j.1540-8167.1996.tb00559.x Hsia, 2009, Relationship of late potentials to the ventricular tachycardia circuit defined by entrainment, J Interv Card Electrophysiol, 26, 21, 10.1007/s10840-009-9421-8 Bogun, 2004, Catheter ablation guided by termination of postinfarction ventricular tachycardia by pacing with nonglobal capture, Heart Rhythm, 1, 422, 10.1016/j.hrthm.2004.06.009 Gokoglan, 2016, Scar homogenization versus limited-substrate ablation in patients with nonischemic cardiomyopathy and ventricular tachycardia, J Am Coll Cardiol, 68, 1990, 10.1016/j.jacc.2016.08.033 Marchlinski, 2004, Electroanatomic substrate and outcome of catheter ablative therapy for ventricular tachycardia in setting of right ventricular cardiomyopathy, Circulation, 110, 2293, 10.1161/01.CIR.0000145154.02436.90 Maury, 2014, Radio-frequency ablation as primary management of well-tolerated sustained monomorphic ventricular tachycardia in patients with structural heart disease and left ventricular ejection fraction over 30%, Eur Heart J, 35, 1479, 10.1093/eurheartj/ehu040 Ryden, 2004, Patient access to medical technology across Europe, Eur Heart J, 25, 611, 10.1016/j.ehj.2004.02.015 Zhang, 2015, Sudden cardiac death in China: current status and future perspectives, Europace, 17 Suppl 2, ii14, 10.1093/europace/euv143 Kober, 2016, Defibrillator implantation in patients with nonischemic systolic heart failure, N Engl J Med, 375, 1221, 10.1056/NEJMoa1608029 Kuck, 2000, Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH), Circulation, 102, 748, 10.1161/01.CIR.102.7.748 Connolly, 2000, Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone, Circulation, 101, 1297, 10.1161/01.CIR.101.11.1297 Olde Nordkamp, 2016, Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: a systematic review and meta-analysis of inappropriate shocks and complications, Heart Rhythm, 13, 443, 10.1016/j.hrthm.2015.09.010 Corrado, 1997, Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study, J Am Coll Cardiol, 30, 1512, 10.1016/S0735-1097(97)00332-X Santangeli, 2012, Examining the safety of amiodarone, Expert Opin Drug Saf, 11, 191, 10.1517/14740338.2012.660915 Riley, 2010, Lack of uniform progression of endocardial scar in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy and ventricular tachycardia, Circ Arrhythm Electrophysiol, 3, 332, 10.1161/CIRCEP.109.919530 Tung, 2008, A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death, J Am Coll Cardiol, 52, 1111, 10.1016/j.jacc.2008.05.058 Katz, 2015, Safety of ventricular tachycardia ablation in clinical practice: findings from 9699 hospital discharge records, Circ Arrhythm Electrophysiol, 8, 362, 10.1161/CIRCEP.114.002336 Komura, 2010, Clinical course of arrhythmogenic right ventricular cardiomyopathy in the era of implantable cardioverter-defibrillators and radiofrequency catheter ablation, Int Heart J, 51, 34, 10.1536/ihj.51.34 Lin, 2018, Heterogeneous distribution of substrates between the endocardium and epicardium promotes ventricular fibrillation in arrhythmogenic right ventricular dysplasia/cardiomyopathy, Europace, 20, 501, 10.1093/europace/euw393